Nour Faqeer
Overview
Explore the profile of Nour Faqeer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
8
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mustafa N, Attili D, Alsoud F, Alsheikh N, Faqeer N
Cureus
. 2025 Feb;
17(1):e77012.
PMID: 39912021
Purpose: This study describes the characteristics of unplanned hospital admissions of patients with cancer. Methods: This prospective study was conducted at King Hussein Cancer Center in Amman, Jordan, from March...
2.
Al-Hadaddin R, Mustafa N, Alyamani A, Faqeer N
J Oncol Pharm Pract
. 2024 Nov;
31(2):276-281.
PMID: 39529359
IntroductionLeukemia, a complex hematological malignancy, requires a multidisciplinary treatment approach, with clinical pharmacists playing a crucial role. However, their involvement in clinical practice is not well-documented in the literature. This...
3.
Faqeer N, Alrabie R, Al-Haddadin R, Makoseh M
J Chemother
. 2023 Oct;
36(4):291-298.
PMID: 37860948
This retrospective study aimed to assess the characteristics and predictors of infusion-related reactions (IRRs) to rituximab in patients with B-cell non-Hodgkin lymphoma (B-NHL). The medical records of adult patients with...
4.
Makoseh M, Farfoura H, Abufara A, Elmusa R, Hushki A, Faqeer N, et al.
Hematology
. 2023 Apr;
28(1):2198898.
PMID: 37114663
Objectives: Patterns and predictors of relapse in primary gastric diffuse large B cell lymphoma (DLBCL) were variably reported. Our study aims to evaluate the patterns and predictors of relapse in...
5.
Zatarah R, Faqeer N, Mahmoud A, Quraan T, Matalka L, Kamal A, et al.
Discov Oncol
. 2022 Oct;
13(1):107.
PMID: 36251222
Purpose: Though febrile neutropenia (FN) risk prediction models are important in clinical practice, their external validation is limited. In this study, we validated the Cycle-Specific Risk of FEbrile Neutropenia after...
6.
Zatarah R, Faqeer N, Quraan T, Mahmoud A, Matalka L, Abu Khadija L, et al.
JNCI Cancer Spectr
. 2022 Jun;
6(3).
PMID: 35689801
Background: The FEbrile Neutropenia after ChEmotherapy (FENCE) score was developed to estimate the risk of febrile neutropenia (FN) at first cycle of chemotherapy but has not been externally validated. We...
7.
Faqeer N, Al Gharabli A, Dalbah M, Ammar K, Agha R, Shannies H, et al.
Sultan Qaboos Univ Med J
. 2022 Mar;
22(1):154-156.
PMID: 35299799
No abstract available.
8.
Faqeer N, Mustafa N, Abd Al-Jalil N, Quran T
J Oncol Pharm Pract
. 2020 Jul;
27(4):897-901.
PMID: 32703083
Introduction: Clinical pharmacy is considered an integral discipline in the health care system for optimizing therapy and reducing drug-related problems. The objective of this study was to evaluate the impact...